By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BiondVax Pharmaceuticals 

Science Park, 14 Einstein Street
P.O. Box 4143
Ness Ziona    74140  Israel
Phone: 972-8-9302529 Fax: 972-8-9302531


Company News
BiondVax Pharmaceuticals Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine Candidate Is Safe And Well Tolerated 11/29/2016 8:35:12 AM
BiondVax Pharmaceuticals Announces Third Quarter 2016 Financial Results And Update 11/28/2016 9:28:36 AM
Highly Pathogenic Bird Flu Spreading Across Europe And Asia; BiondVax Pharmaceuticals’s Universal Flu Vaccine Candidate Also Covers These Potential Pandemic Strains 11/22/2016 9:03:38 AM
BiondVax Pharmaceuticals Phase 2b European Trial: Last Patient Out 9/21/2016 11:00:52 AM
Professor Shai Ashkenazi Appointed To BiondVax Pharmaceuticals's Scientific Advisory Board 9/7/2016 9:44:20 AM
BiondVax Pharmaceuticals Announces Second Quarter 2016 Financial Results And Update 8/19/2016 7:02:46 AM
BiondVax Pharmaceuticals Invited To WHO Influenza Vaccine Meeting 8/10/2016 11:41:03 AM
BIO2016: BiondVax Pharmaceuticals CEO To Present Universal Flu Vaccine Technology At BIO International Convention 6/2/2016 11:23:53 AM
BiondVax Pharmaceuticals Announces First Quarter 2016 Financial Results and Update 6/1/2016 9:46:39 AM
BiondVax Pharmaceuticals To Present Tomorrow At Joseph Gunner Pioneers 2016 Conference 5/4/2016 10:14:35 AM